Defining Adherence in Acceptance and Commitment Therapy Adherence, within the context of Acceptance and Commitment Therapy (ACT), refers specifically to the degree to which a clinician’s practice aligns with the theoretical model and established treatment protocols of ACT. Unlike adherence in more traditional cognitive behavioral models which often focus heavily on the strict delivery of […]
Defining Addiction Treatment Satisfaction Addiction treatment satisfaction is a complex, multifaceted construct representing the client’s subjective evaluation of the quality, suitability, and effectiveness of the services received during the recovery process. This satisfaction is not merely a passive feeling of contentment; rather, it is an active cognitive and emotional assessment based on the comparison between […]
Attitude toward Medication for treatment of ADHD The management of Attention-Deficit/Hyperactivity Disorder (ADHD), a prevalent neurodevelopmental condition affecting millions globally, relies heavily on a multimodal approach, with pharmacological intervention serving as the cornerstone for many individuals. Despite the well-documented efficacy of prescribed medications—primarily stimulants and, secondarily, non-stimulants—in ameliorating core symptoms such as inattention, hyperactivity, and […]
Overview and Goals of Anorexia Nervosa Treatment Anorexia Nervosa (AN) presents one of the most complex challenges in clinical psychology and medicine, requiring a highly specialized, multidisciplinary approach to treatment. The overarching goal is not merely weight restoration, but comprehensive physical and psychological recovery, addressing the underlying psychopathology that drives restrictive eating and body image […]
Antidepressant Selection: A Clinical Framework The process of selecting an appropriate antidepressant medication is a complex, nuanced endeavor that requires a thorough understanding of psychopharmacology, differential diagnosis, patient history, and individualized risk assessment. It is not merely a trial-and-error process, but rather a structured clinical framework designed to maximize efficacy while minimizing adverse effects. The […]
Antidepressant Appropriateness: A Clinical Imperative The determination of antidepressant appropriateness represents one of the most complex and nuanced decisions in modern psychopharmacology. It extends far beyond merely confirming a diagnosis of Major Depressive Disorder (MDD); rather, it necessitates a holistic evaluation of the patient’s biological profile, psychological history, social context, and specific symptom presentation. Appropriate […]
The history of treating major depressive disorder (MDD) is a chronicle of profound scientific discovery, shifting paradigms, and, often, sheer serendipity. For centuries, depression—or melancholia, as it was historically termed—was treated with ineffective, often harmful methods ranging from institutionalization and hydrotherapy to opium and herbal remedies. The modern era of psychopharmacology, which began in the […]
Introduction to Antidepressant Side-Effects Antidepressant medications represent a cornerstone in the pharmacological management of major depressive disorder (MDD), anxiety disorders, and certain chronic pain conditions. While highly effective for many patients, their therapeutic utility is often counterbalanced by a wide spectrum of potential adverse drug reactions (ADRs). The profile of side effects is highly dependent […]
Antipsychotic Medication Management Fidelity: Introduction and Conceptual Foundation Antipsychotic Medication Management (AMM) Fidelity represents a critical metric within psychopharmacology, particularly in the treatment of severe mental illnesses such as schizophrenia, schizoaffective disorder, and severe bipolar disorder. Fidelity, in this context, refers to the precise degree to which a therapeutic intervention, encompassing both the prescribed medication […]
Introduction to Antipsychotic Long-Acting Injections (LAIs) Antipsychotic Long-Acting Injections, frequently referred to as depot antipsychotics, represent a crucial pharmacological advancement in the management of chronic psychotic disorders, most notably schizophrenia and schizoaffective disorder. These formulations are designed to deliver medication slowly and consistently over an extended period, typically ranging from two weeks to three months, […]